Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Direct Acting Antiviral Agents”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01838590
What this trial is testing

Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus
Gilead Sciences 103
Not applicableUnknownNCT03687229
What this trial is testing

The Effect Of DAAs on miRNA-122 And Insulin Resistance In Chronic HCV Patients

Who this might be right for
Chronic Hepatitis c
Assiut University 60
Large-scale testing (Phase 3)Study completedNCT02822794
What this trial is testing

Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing Regimen

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 117
Not applicableStudy completedNCT03318887
What this trial is testing

Impact of Sofosbuvir and Daclatasvir Concentration on HCV RNA

Who this might be right for
Hepatitis C
Hospices Civils de Lyon 130
Testing effectiveness (Phase 2)Study completedNCT01805882
What this trial is testing

Combination Therapy for Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
National Institute of Allergy and Infectious Diseases (NIAID) 229
Large-scale testing (Phase 3)Study completedNCT02472886
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 153
Not applicableStudy completedNCT02526641
What this trial is testing

Macrophages, Portal Hypertension, and Liver Function During AbbVie Treatment of Chronic Hepatitis C

Who this might be right for
Hepatitis C
University of Aarhus 16
Large-scale testing (Phase 3)UnknownNCT03444272
What this trial is testing

Effect of Direct-acting Antiviral Drugs on Erectile Function

Who this might be right for
Hepatitis C
Sherief Abd-Elsalam 105
Large-scale testing (Phase 3)Study completedNCT01625338
What this trial is testing

Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 534
Testing effectiveness (Phase 2)Study completedNCT02470858
What this trial is testing

Triple DAAs Regimen in Treating Non-cirrhotic HCV GT1b Subjects

Who this might be right for
Chronic Hepatitis C Infection
Humanity and Health Research Centre 18
Testing effectiveness (Phase 2)Ended earlyNCT02605304
What this trial is testing

12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF

Who this might be right for
HIV-1 InfectionHepatitis C
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 7
Large-scale testing (Phase 3)Study completedNCT01768286
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 441
Not applicableUnknownNCT03414554
What this trial is testing

Risk of HCC in Cirrhotic Patients Post DAAs Ttt

Who this might be right for
HCC
Assiut University 100
Not applicableUnknownNCT03894696
What this trial is testing

Frequency of Anxiety and Depression in Chronic Hepatitis C Patients Recieving Direct-Acting Antiviral Agents

Who this might be right for
Chronic Hepatitis c
Assiut University 200
Testing effectiveness (Phase 2)Study completedNCT01726517
What this trial is testing

Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 100
Large-scale testing (Phase 3)Study completedNCT02639247
What this trial is testing

Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 333
Not applicableApproved For MarketingNCT01779518
What this trial is testing

Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C

Who this might be right for
Post-transplant Hepatitis C
Gilead Sciences
Large-scale testing (Phase 3)Study completedNCT01542788
What this trial is testing

Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 278
Not applicableStudy completedNCT03346941
What this trial is testing

Side Effects After Direct-acting Antiviral Treatment

Who this might be right for
Chronic Hepatitis c
Hospices Civils de Lyon 95
Not applicableUnknownNCT02836782
What this trial is testing

HIV-DNA Dynamics in HIV Monoinfected or HIV/HCV Coinfected Patients

Who this might be right for
HIV
Catholic University of the Sacred Heart 600
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation